At a glance
ClinicalIndex Comparison RecordN/ACompleted· 32 enrolled
Drug / intervention
Bi-homonal Bionic Pancreas +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Beacon Hill Study: Feasibility of Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas
In Brief
A clinical study evaluating Bi-homonal Bionic Pancreas and Usual care for Type 1 Diabetes. Completed, enrolled 32 participants across 1 site.
Detailed Summary
This study will test the hypothesis that a wearable automated bionic pancreas system that automatically delivers both insulin and glucagon can improved glycemic control vs. usual in the outpatient environment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
CollaboratorsBoston University
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2013
First PostedJan 2013
Primary CompletionOct 2013
Study CompletionJun 2014
TodayJul 2026
First PostedJan 7, 2013
Enrollment StartJan 1, 2013
Primary CompletionOct 1, 2013
Study CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 13.5 years ago
Interventions
Bi-homonal Bionic Pancreasdevice
A computer algorithm will automatically deliver insulin lispro and glucagon based on the signal from a minimally invasive continuous glucose monitor.
Usual careother